Hu et al., 2022 - Google Patents
Characteristics, pathogenic mechanism, zoonotic potential, drug resistance, and prevention of avian pathogenic Escherichia coli (APEC)Hu et al., 2022
View HTML- Document ID
- 11443497588353662159
- Author
- Hu J
- Afayibo D
- Zhang B
- Zhu H
- Yao L
- Guo W
- Wang X
- Wang Z
- Wang D
- Peng H
- Tian M
- Qi J
- Wang S
- Publication year
- Publication venue
- Frontiers in Microbiology
External Links
Snippet
Although most Escherichia coli (E. coli) strains are commensal and abundant, certain pathogenic strains cause severe diseases from gastroenteritis to extraintestinal infections. Extraintestinal pathogenic E. coli (ExPEC) contains newborn meningitis E. coli (NMEC) …
- 241000588724 Escherichia coli 0 title abstract description 152
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hu et al. | Characteristics, pathogenic mechanism, zoonotic potential, drug resistance, and prevention of avian pathogenic Escherichia coli (APEC) | |
| Kathayat et al. | Avian pathogenic Escherichia coli (APEC): an overview of virulence and pathogenesis factors, zoonotic potential, and control strategies | |
| Johnson et al. | Current and potential treatments for reducing Campylobacter colonization in animal hosts and disease in humans | |
| Cheng et al. | Embracing diversity: differences in virulence mechanisms, disease severity, and host adaptations contribute to the success of nontyphoidal Salmonella as a foodborne pathogen | |
| Lamas et al. | A comprehensive review of non-enterica subspecies of Salmonella enterica | |
| Dziva et al. | Colibacillosis in poultry: unravelling the molecular basis of virulence of avian pathogenic Escherichia coli in their natural hosts | |
| Guabiraba et al. | Avian colibacillosis: still many black holes | |
| Lin | Novel approaches for Campylobacter control in poultry | |
| Foley et al. | Salmonella pathogenicity and host adaptation in chicken-associated serovars | |
| Haiko et al. | The role of the bacterial flagellum in adhesion and virulence | |
| Foley et al. | Population dynamics of Salmonella enterica serotypes in commercial egg and poultry production | |
| Nolan et al. | Resistance to serum complement, iss, and virulence of avian Escherichia coli | |
| Breland et al. | An overview of two-component signal transduction systems implicated in extra-intestinal pathogenic E. coli infections | |
| Arenas-Hernández et al. | Clinical implications of enteroadherent Escherichia coli | |
| Ho et al. | Pathogenicity, host responses and implications for management of enterohemorrhagic Escherichia coli O157: H7 infection | |
| Kunert Filho et al. | Avian Pathogenic Escherichia coli (APEC)-an update on the control | |
| Mobley et al. | Uropathogenic Escherichia coli | |
| Naghizadeh et al. | Effect of serum anti-phage activity on colibacillosis control by repeated phage therapy in broilers | |
| Marandi et al. | Immunization against Vibrio cholerae, ETEC, and EHEC with chitosan nanoparticle containing LSC chimeric protein | |
| Ali et al. | Escherichia coli in broiler chickens in Egypt, its virulence traits and vaccination as an intervention strategy | |
| Hughes et al. | Towards development of a non-toxigenic Clostridioides difficile oral spore vaccine against toxigenic C. difficile | |
| Trampel et al. | Characterization of Escherichia coli isolates from peritonitis lesions in commercial laying hens | |
| Stromberg et al. | Characterization of spleen transcriptome and immunity against avian colibacillosis after immunization with recombinant attenuated Salmonella vaccine strains | |
| Kabir et al. | Colibacillosis and its impact on egg production | |
| Maddux et al. | Evaluation of recombinant attenuated Salmonella vaccine strains for broad protection against extraintestinal pathogenic Escherichia coli |